top of page
shutterstock_1504697936 (1).jpg

OUR COMPANY

Our Story

Registered in Singapore in 2016, FEGO Biotech Pte Ltd primary focus is in the field of healthcare immunology and immune-therapy.

​

With the proprietary technologies and intellectual properties of the company principal founder and scientist, Dr. LIM Kah Meng, FEGO Biotech focuses on developing new “smart” health supplements to promote immune wellness and probable cures for chronic ailments and diseases such as auto-immune disorders and cancers.

​

FEGO Biotech believes in scientific and evidence-based formulation of immuno-wellness consumables and would try to set the benchmark for supplement efficacy and reliability. Known as the 1st Business Pillar of Precision Medicine, the company launched its signature immuno-supplement, G’NEST, in April 2018. Complementing this scientifically formulated nutraceutical, the company has an in-house proprietary RNA saliva-based diagnostic assessment kit that can detect several types of cancer markers and one other marker on the auto-immune disorder probability. Together, this would allow highly personalized medical consultation for our clients with our panel of doctors.

​

The company intends to advance into prescriptive immuno-medicine in the field of biosimilars applications where a person’s well-being goes beyond just nourishing or improving the state of wellness.  Known as the 2nd Business Pillar of Biosimilars, the company’s approach in developing and/or manufacturing Biosimilars is one prong of strong strategic growth.

Researches into immuno-cell therapy including the CAR-T trials is FEGO Biotech 3rd Business Pillar of Immuno-Cell Therapy. Our research and development capabilities encompass discovery, translational medicine, pre-clinical development and clinical development, as well as business development functions. These integrated capabilities are strengthened by our deep understanding of Asia’s cell therapies regulatory framework combined with our direct access to extensive preclinical and clinical trial resources in China and Southeast Asia.

​

Committed to its core values – Innovation, Integrity and Leadership – FEGO Biotech Pte Ltd aims to be a biotechnology leader in this space and intends to grow into a capital unicorn.

What We Do

FEGO Biotech works on 2 strategic fronts and delivers through 3 business pillars.

Precision Medicine
Biosimiliars
Immuno-Cell Therapy Growth Model

Meet The Team

WhatsApp Image 2021-11-02 at 23.49.08.jpeg

Jenny Lee

Business Development Director

Our Team

Our Partners

Gene-Oasis_edited.jpg
StarMed_edited.jpg
Nutrisyz_edited.jpg
Astar_edited.jpg
Theertha_edited.jpg
Sinopharm_edited.jpg
Temposcan_edited.jpg
NFG_edited.jpg
Alpha-Lab_edited.jpg
Our Partners
bottom of page